Proxy Votes Now

Home › Funds › T. Rowe Price › T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund

T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund (PRDSX) proxy voting record 2025-2026

Fund family: T. Rowe Price · Filed by T. Rowe Price Integrated Equity Funds, Inc. (CIK 1038469) · SEC series S000002074

Share classes and tickers: PRDSX (C000005434), TQAAX (C000170855), TQAIX (C000169956)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,621 with, 9 against, 0 abstentions (not counted as with management); 1 items carried no recommendation. Shareholder proposals: 3 FOR, 7 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with T. Rowe Price as a whole

The same two figures as T. Rowe Price’s manager page (244,024 ballot items across 112 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsT. Rowe PriceItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)89.7%2,56093.7%208,710
Backed environmental and social shareholder proposals at US companiesn/a32.6%3,333

Where this fund voted differently from most T. Rowe Price funds

Each ballot item this fund voted is set against the votes of the other T. Rowe Price funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most T. Rowe Price funds on 53 items (2.2% of the 2,416 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost T. Rowe Price fundsMgmtResult
Birkenstock Holding Plc2026-04-29Amend Articles of AssociationForAGAINST — 11 of 14 T. Rowe Price fundsFor—
Birkenstock Holding Plc2026-04-29Elect Director Ruth KennedyForAGAINST — 11 of 14 T. Rowe Price fundsFor—
Cytokinetics, Incorporated2026-05-272 wordings Election of Class I Directors for terms expiring in 2029: Edward M. Kaye, M.D.WithholdFOR — 15 of 22 T. Rowe Price fundsAgainstPassed (calculated), 97.0% support
Adaptive Biotechnologies Corporation2026-06-05To elect two Class I director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2029 annual meeting of shareholders: Robert Hershberg, PhD, MDForWITHHOLD — 7 of 9 T. Rowe Price fundsFor—
IonQ, Inc.2026-06-16To elect two Class II directors to hold office until our 2029 Annual Meeting of Stockholders and until a successor is duly elected and qualified or until earlier resignation or removal: Kathryn K. ChouWithholdFOR — 6 of 8 T. Rowe Price fundsAgainstElected, 71.3% support
IonQ, Inc.2026-06-16To elect two Class II directors to hold office until our 2029 Annual Meeting of Stockholders and until a successor is duly elected and qualified or until earlier resignation or removal: William F. ScannellWithholdFOR — 6 of 8 T. Rowe Price fundsAgainstElected, 83.0% support
Kadant Inc.2026-05-20Election of two directors to the class to be elected for a three-year term expiring in 2029: Thomas C. LeonardAgainstFOR — 6 of 8 T. Rowe Price fundsAgainst—
Element Solutions Inc2026-05-04Election of Directors: E. Stanley O'NealForAGAINST — 7 of 10 T. Rowe Price fundsForPassed (calculated), 94.2% support
ESCO Technologies Inc.2026-01-30Election of Directors: Patrick M. DewarWithholdFOR — 7 of 10 T. Rowe Price fundsAgainstElected, 96.4% support
ESCO Technologies Inc.2026-01-30Election of Directors: Vinod M. KhilnaniWithholdFOR — 7 of 10 T. Rowe Price fundsAgainstElected, 96.6% support
Ambarella, Inc.2026-06-26Election of Directors: D. Jeffrey RichardsonWithholdFOR — 7 of 10 T. Rowe Price fundsAgainstElected, 89.0% support
Ambarella, Inc.2026-06-26Election of Directors: Elizabeth M. SchwartingWithholdFOR — 7 of 10 T. Rowe Price fundsAgainstElected, 80.4% support
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: David Alexander PlouffeWithholdFOR — 8 of 12 T. Rowe Price fundsAgainstPassed (calculated), 99.5% support
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: Siddhartha SankaranWithholdFOR — 8 of 12 T. Rowe Price fundsAgainstPassed (calculated), 99.7% support
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: William (Bill) J. Gassen IIIWithholdFOR — 8 of 12 T. Rowe Price fundsAgainstPassed (calculated), 96.9% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Abid RizviAgainstFOR — 9 of 14 T. Rowe Price fundsAgainstPassed (calculated), 97.8% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Alissa AhlmanAgainstFOR — 9 of 14 T. Rowe Price fundsAgainstPassed (calculated), 97.8% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Mary BaglivoAgainstFOR — 9 of 14 T. Rowe Price fundsAgainstPassed (calculated), 97.8% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Richard ZanninoAgainstFOR — 9 of 14 T. Rowe Price fundsAgainstPassed (calculated), 95.8% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Robert FischAgainstFOR — 9 of 14 T. Rowe Price fundsAgainstPassed (calculated), 97.3% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Stanley FleishmanAgainstFOR — 9 of 14 T. Rowe Price fundsAgainstPassed (calculated), 90.7% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Stephen WhiteAgainstFOR — 9 of 14 T. Rowe Price fundsAgainstPassed (calculated), 97.5% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Thomas HendricksonAgainstFOR — 9 of 14 T. Rowe Price fundsAgainstPassed (calculated), 97.0% support
Element Solutions Inc2026-05-04Advisory vote to approve the Company's 2025 executive compensationAgainstFOR — 8 of 13 T. Rowe Price fundsAgainstFailed (calculated), 41.4% support
Dutch Bros Inc.2026-05-13Election of Directors: Todd PenegorForAGAINST — 10 of 17 T. Rowe Price fundsForElected, 91.7% support
Show all 53
Items 26 to 53.
CompanyMeetingItemThis fundMost T. Rowe Price fundsMgmtResult
Dutch Bros Inc.2026-05-13Election of Directors: Travis BoersmaForAGAINST — 10 of 17 T. Rowe Price fundsForElected, 95.6% support
Almonty Industries Inc.2026-06-09Elect Director Andrew FrazerForAGAINST — 9 of 15 T. Rowe Price fundsFor—
Almonty Industries Inc.2026-06-09Elect Director Daniel D'AmatoForAGAINST — 9 of 15 T. Rowe Price fundsFor—
Almonty Industries Inc.2026-06-09Elect Director David HanickForAGAINST — 9 of 15 T. Rowe Price fundsFor—
Almonty Industries Inc.2026-06-09Elect Director Lewis BlackForAGAINST — 9 of 15 T. Rowe Price fundsFor—
Almonty Industries Inc.2026-06-09Elect Director Mark TrachukForAGAINST — 9 of 15 T. Rowe Price fundsFor—
Advanced Energy Industries, Inc.2026-05-07Approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan; andAgainstFOR — 6 of 9 T. Rowe Price fundsAgainstApproved, 78.4% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Amin N. MarediaAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 98.7% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Edward N. AntoianAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 97.6% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Harry S. Cherken, Jr.AgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 98.4% support
Urban Outfitters, Inc.2026-06-03Election of Directors: John C. MullikenAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 97.7% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Kelly CampbellAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 99.3% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Mary C. EganAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 98.7% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Todd R. MorgenfeldAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 99.1% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Wesley S. McDonaldAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 98.3% support
Interparfums, Inc.2025-09-10To vote for the advisory resolution to approve executive compensation.AgainstFOR — 7 of 11 T. Rowe Price fundsAgainstApproved, 84.3% support
Marqeta, Inc.2026-06-10To approve an amendment to our Amended and Restated Certificate of Incorporation to provide for officer exculpation as permitted by Delaware law.ForAGAINST — 7 of 11 T. Rowe Price fundsForPassed (calculated), 78.7% support
Marqeta, Inc.2026-06-10To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Judson (Jud) LiForWITHHOLD — 7 of 11 T. Rowe Price fundsForPassed (calculated), 92.2% support
Marqeta, Inc.2026-06-10To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Martha CummingsForWITHHOLD — 7 of 11 T. Rowe Price fundsForPassed (calculated), 82.1% support
Marqeta, Inc.2026-06-10To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Najuma AtkinsonForWITHHOLD — 7 of 11 T. Rowe Price fundsForPassed (calculated), 87.8% support
Marqeta, Inc.2026-06-10To approve, on a non-binding advisory basis, the compensation of our named executive officers.ForAGAINST — 8 of 14 T. Rowe Price fundsForPassed (calculated), 78.5% support
MapLight Therapeutics, Inc.2026-06-23To elect the three Class I Director nominees named in the Proxy Statement to serve until the 2029 annual meeting of our stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Martin BablerForWITHHOLD — 8 of 14 T. Rowe Price fundsFor—
Installed Building Products, Inc.2026-05-19Election of Directors to serve for three-year terms: Robert H. SchottensteinAgainstFOR — 7 of 12 T. Rowe Price fundsAgainstElected, 93.9% support
Xenon Pharmaceuticals Inc.2026-06-02To approve the Corporation's 2026 Equity Incentive Plan;AgainstFOR — 7 of 12 T. Rowe Price fundsAgainstApproved, 68.0% support
Kodiak Sciences Inc.2026-06-02Elect three Class II directors nominated by our board and named in this proxy statement: Charles A. BancroftForWITHHOLD — 8 of 15 T. Rowe Price fundsForElected, 78.7% support
Denali Therapeutics Inc.2026-06-03ELECTION OF DIRECTORS: David Schenkein, M.D.ForWITHHOLD — 8 of 15 T. Rowe Price fundsForElected, 73.5% support
Denali Therapeutics Inc.2026-06-03ELECTION OF DIRECTORS: Jennifer CookForWITHHOLD — 8 of 15 T. Rowe Price fundsForElected, 60.9% support
Impinj, Inc.2026-05-28Election of Directors: Steve SanghiForAGAINST — 7 of 13 T. Rowe Price fundsForElected, 68.1% support

Download all 53 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 94.2% of this fund’s 2,630 such votes could be given a sector; the other 153 (5.8%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care58810.2%
Consumer Discretionary53420.4%
Industrials44740.9%
Technology42220.5%
Finance18100.0%
Real Estate9600.0%
Energy8300.0%
Consumer Staples3800.0%
Miscellaneous3700.0%
Basic Materials3400.0%
Telecommunications1300.0%
Utilities400.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections1,8150
Say-on-Pay3150
Audit-related3120
Compensation960
Corporate Governance555
Capital Structure350
Extraordinary Transactions150
Shareholder Rights and Defenses111
Other Social Issues21
Diversity, Equity, and Inclusion11

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Bloom Energy CorporationMay 21, 2026$135M80
Guardant Health, Inc.June 17, 2026$125M50
BrightSpring Health Services, Inc.May 21, 2026$114M50
Rambus Inc.April 23, 2026$94M60
Watts Water Technologies, Inc.May 19, 2026$92M110
InterDigital, Inc.June 10, 2026$87M110
Applied Industrial Technologies, Inc.October 21, 2025$83M50
Carpenter Technology CorporationOctober 7, 2025$82M50

Notable votes against management

MeetingCompanyProposalFundMgmt
September 3, 2025Casey's General Stores, Inc.Shareholder proposal regarding Scope 3 greenhouse gas reduction targets. Shareholder proposalAgainstFor
May 6, 2026Entegris, Inc.Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders. Shareholder proposalAgainstFor
May 11, 2026MKS Inc.A shareholder proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 10%, if properly presented at the meeting. Shareholder proposalAgainstFor
April 28, 2026The Brink's CompanyAct upon a shareholder proposal requesting a report on employee retention rates by demographic categories. Shareholder proposalAgainstFor
August 4, 2025Eagle Materials Inc.Non-binding advisory stockholder proposal requesting the declassification of our Board of Directors. Shareholder proposalForAgainst
May 15, 2026Medpace Holdings, Inc.Stockholder proposal regarding giving shareholders an ability to call for a special shareholder meeting, if properly presented at the meeting. Shareholder proposalAgainstFor
July 23, 2025Booz Allen Hamilton Holding CorporationVote on a stockholder proposal regarding a report on political spending. Shareholder proposalAgainstFor
June 15, 2026HubSpot, Inc.A stockholder proposal to change the Company's Sixth Amended and Restated Bylaws to allow 10% holders of the Company's stock the ability to call a special meeting; and Shareholder proposalForAgainst
June 3, 2026Power Integrations, Inc.To consider, if properly presented at the Annual Meeting, a stockholder proposal related to the separation of the office of Chairman of the Board and the office of Chief Executive Officer. Shareholder proposalAgainstFor

Search this fund’s votes by company

2,659 ballot items at 320 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund (PRDSX) voted at 320 shareholder meetings of 315 companies, on 2,659 ballot items in all. Where management made a recommendation, the fund followed it on 99.7% of the items and voted against it 9 times. Its most frequent area of disagreement was corporate governance (5 of its votes against management). It voted on 10 shareholder proposals. It voted FOR the board's own proposals less often than T. Rowe Price's funds as a whole (89.7% against 93.7%). It voted differently from most T. Rowe Price funds on 53 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of T. Rowe Price’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.